首页> 外文OA文献 >Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma
【2h】

Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma

机译:低通量光动力疗法与玻璃体内兰尼单抗联合治疗脉络膜骨瘤中脉络膜新生血管膜的联合治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Choroidal osteoma is an unusual form of intraocular calcification seen in otherwise healthy eyes. It is a benign idiopathic osseous tumor of the choroid, typically seen in young females. Choroidal neovascular membrane (CNVM) is a complication seen in one-third of these patients and carries a poor visual outcome. We report a case of a 25-year-old hyperthyroid female with choroidal osteoma and subfoveal CNVM in her left eye which was successfully treated using low-fluence photodynamic therapy (PDT) with verteporfin followed by a single injection of intravitreal ranibizumab.
机译:脉络膜骨瘤是健康眼中不常见的眼内钙化形式。它是脉络膜的良性特发性骨瘤,通常见于年轻女性。脉络膜新生血管膜(CNVM)是其中三分之一的患者所见的并发症,并且视觉效果较差。我们报道了一名25岁甲状腺功能亢进女性的左眼脉络膜骨瘤和小凹下CNVM病例,该患者已成功通过低剂量光动力疗法(PDT)联合维替泊芬治疗,随后单次注射玻璃体内兰尼单抗治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号